Association Between Uric Acid and Acute Coronary Syndrome

March 3, 2023 updated by: Hadeer Hassan Abdelaty, Sohag University

The Association Between Serum Uric Acid Level and Acute Coronary Syndrome in_hospital Outcomes

The aim of the study is to acess the association between admission serum uric acid level and in_hospital outcomes in patients with acute coronary syndromes

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Prospective study

  1. To acess patients with acute coronary syndrome including one of (typical Chest pain _ECGchanges _elevated cardic enzyme)
  2. the complication occur in patients with hyperurecemia and those with normal uric acid

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Hassan A Hassanin
  • Phone Number: 01003459741

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All Patient admited to sohag University in CCU with acute coronary syndrome

Description

Inclusion Criteria:

all patients with acute coronary syndrome with one of the Following

  • Typical Chest pain
  • ECG changes
  • Elevated cardiac enzyme

Exclusion Criteria:

  • patients aged less than 18 years
  • patients with gout
  • patients with treated with diuretics
  • Patient with CKD
  • Patient with chronic haemolytic anemia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with normal uric acid levels
Patient with uric acid level (2.5_6)for femal and (3_7)for males
Diagnostic test: Uric acid level
Uric acid will be measured for all Patients with acute coronary syndrome and result will be analysed
Patients with elevated uric acid level (hyperurecemia)
Uric acid level more than 7 for males and more than 6 for female
Diagnostic test: Uric acid level
Uric acid will be measured for all Patients with acute coronary syndrome and result will be analysed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between serum uric acid level and acute coronary syndrome in hospital outcomes
Time Frame: From the day of admission and 30 days post discharge
Comparision between Patient with hyperurecemia and those with normal uric acid level
From the day of admission and 30 days post discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 22, 2023

Primary Completion (Anticipated)

February 22, 2024

Study Completion (Anticipated)

March 22, 2024

Study Registration Dates

First Submitted

February 22, 2023

First Submitted That Met QC Criteria

March 3, 2023

First Posted (Actual)

March 15, 2023

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 3, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Uric acid in ACSs

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Clinical Trials on Uric acid level

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe